Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Revolution Medicines, Inc. RVMD

Set alert

Price alert · RVMD

All alert types
188.17 USD -3.14 -1.64%

At close

189.72 +1.55 +0.82%

Pre-market · Nov 3, 4:00 AM ET

Bid
188.16 × 2
Ask
188.32 × 2
187.12 Day range 192.98
56.66 52-week range 224.31
YTD
+136.25%
1 year
+219.80%
Open
190.71
Prev close
191.31
Mkt cap
40.33B
Vol
1.37M
Avg vol
1.93M
EPS
-8.73
P/E
0.00
Div yield
0.00%
More statistics
Low
187.12
High
192.98
Forward P/E
-32.65
Beta
1.43
Short ratio
5.55
Inst. own
103.33%
Dividend
0.00
Ex-div date
Earnings
Nov 4, 2026
50-d avg
199.22
200-d avg
156.04
1y target
258.84

5D chart

Chart tools
Interval
1m5m15m30m

Signals (144)
NameTimeAgo
MACD: Sell SignalNov 2, 3:55 PM13 hours ago
SMA: BearishNov 2, 3:50 PM13 hours ago
SMA: BearishNov 2, 3:50 PM13 hours ago
SMA: BullishNov 2, 3:45 PM13 hours ago
SMA: BullishNov 2, 3:40 PM13 hours ago
SMA: BearishNov 2, 3:35 PM13 hours ago
SMA: BearishNov 2, 3:30 PM13 hours ago
SMA: BullishNov 2, 2:55 PM14 hours ago
SMA: BullishNov 2, 2:55 PM14 hours ago
MACD: Buy SignalNov 2, 2:55 PM14 hours ago
MACD: Sell SignalNov 2, 2:30 PM14 hours ago
SMA: BearishNov 2, 2:25 PM14 hours ago
SMA: BearishNov 2, 2:15 PM14 hours ago
SMA: BullishNov 2, 2:10 PM14 hours ago
MACD: Buy SignalNov 2, 2:05 PM14 hours ago
SMA: BullishNov 2, 2:00 PM14 hours ago
SMA: BearishNov 2, 1:50 PM15 hours ago
SMA: BullishNov 2, 1:45 PM15 hours ago
SMA: BearishNov 2, 1:25 PM15 hours ago
SMA: BullishNov 2, 1:20 PM15 hours ago

Newest 20 of 144.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 258.84 +37.6% upside
Target (low)
179.00
Target (mean)
258.84
Target (high)
320.00
Ratings (0m) 25 24 buy · 1 hold · 0 sell
  • Strong buy5
  • Buy19
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 25
  • 1 month ago 23
  • 2 months ago 22

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

RVMD analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-2.38-3.24 – -2.07-1.61-47.9%27.35M0.0%21
Next quarter-1.98-3.53 – -0.53-1.86-6.3%167.43M0.0%21
Current year-9.58-12.17 – -8.21-5.95-61.0%200.82M0.0%24
Next year-5.76-9.91 – -1.91-9.58+39.8%1.26B+526.6%24

Upgrades and downgrades

The latest rating changes

RVMD analyst upgrades and downgrades
DateFirmActionFromTo
Oct 21, 2026TD CowenReiteratedBuyBuy
Oct 19, 2026Truist SecuritiesMaintainedBuyBuy
Oct 16, 2026William BlairInitiated—Outperform
Oct 15, 2026NeedhamReiteratedBuyBuy
Oct 14, 2026RBC CapitalMaintainedOutperformOutperform
Oct 8, 2026RBC CapitalMaintainedOutperformOutperform
Oct 7, 2026Truist SecuritiesMaintainedBuyBuy
Sep 28, 2026Brookline CapitalInitiated—Buy
Sep 21, 2026B of A SecuritiesMaintainedBuyBuy
Sep 10, 2026Morgan StanleyInitiated—Overweight
Sep 9, 2026StifelMaintainedBuyBuy
Aug 31, 2026NeedhamMaintainedBuyBuy
Aug 28, 2026UBSMaintainedBuyBuy
Aug 28, 2026GuggenheimMaintainedBuyBuy
Aug 27, 2026OppenheimerMaintainedOutperformOutperform
Aug 27, 2026RBC CapitalMaintainedOutperformOutperform
Aug 27, 2026WedbushMaintainedOutperformOutperform
Aug 27, 2026Truist SecuritiesMaintainedBuyBuy
Aug 27, 2026Evercore ISI GroupMaintainedOutperformOutperform
Aug 27, 2026HC Wainwright & Co.MaintainedBuyBuy
Aug 21, 2026BernsteinMaintainedMarket PerformMarket Perform
Aug 11, 2026Truist SecuritiesMaintainedBuyBuy
Aug 6, 2026RBC CapitalMaintainedOutperformOutperform
Aug 6, 2026WedbushMaintainedOutperformOutperform
Aug 6, 2026Evercore ISI GroupMaintainedOutperformOutperform
Aug 6, 2026GuggenheimMaintainedBuyBuy
Aug 6, 2026NeedhamMaintainedBuyBuy
Jul 23, 2026WedbushMaintainedOutperformOutperform
Jul 20, 2026NeedhamMaintainedBuyBuy
Jul 9, 2026GuggenheimMaintainedBuyBuy